---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-009066"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2024-07-17T23:59:59+00:00"
generated_at: "2026-05-31T20:14:44.949264+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nasdaq notifies ENDRA Life Sciences of delisting due to bid price; company to appeal

## Summary
- Stock closed below $0.10 for 10 consecutive trading days ended July 12, triggering delisting under Nasdaq Rule 5810(c)(3)(A)(iii).
- Company requested hearing on July 16; hearing request automatically stays delisting pending panel decision.
- At August 6 annual meeting, company will seek stockholder approval for reverse stock split at ratio between 1:20 and 1:50.
- No assurance that Nasdaq panel will grant compliance period or that company will ultimately regain listing compliance.

## SEC filing metadata
- accession: 0001654954-24-009066
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2024-07-17T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000165495424009066/0001654954-24-009066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000165495424009066/ndra_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-009066
- JSON: https://secwatch.observer/filing/0001654954-24-009066.json
- Plain text: https://secwatch.observer/filing/0001654954-24-009066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.